Artificial Intelligence Drug R&D
Market
Artificial Intelligence Drug R&D Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Artificial Intelligence Drug R&D Market Size and Growth
The Artificial Intelligence Drug R&D market is experiencing robust growth, driven by advancements in AI technologies and increased pharmaceutical investments. The market is projected to reach approximately $3.5 billion by 2025, reflecting a CAGR of over 30%. Current conditions favor innovation, streamlining drug discovery processes, and enhancing efficiency in research.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ IBM Watson
◍ BioXel
◍ Insilico Medicine
◍ Gatehouse Bio
◍ Google DeepMind
◍ Genpact Cora
◍ Cyclica Inc
◍ QuantumBlack
◍ Nq Medical
◍ Phenomic AI
◍ Palantir Technologies
The AI drug R&D market features key players like IBM Watson, Insilico Medicine, and DeepMind, leveraging AI for drug discovery, predictive modeling, and patient data analysis. These innovations enhance efficiency and reduce costs. Sales figures include IBM approximately $57 billion (2022) and Genpact around $4 billion (2022).
Request Sample Report
Market Segmentation
By Application
Drug Discovery
Precision Medicine
Request Sample Report
By Product
AI Platfrom
Analytics Service
Market Growth
Request Sample Report
$ X Billion USD
